Pinealon: What It Is and Its U.S. Regulatory Status

What is Pinealon?

Pinealon is a very short synthetic peptide made of three amino acids: glutamic acid, aspartic acid and arginine (Glu-Asp-Arg). It belongs to a group of short peptides developed by researchers in Russia, sometimes described as peptide bioregulators.

Published research on Pinealon is limited and comes mostly from laboratory and animal studies. It has not been established as safe or effective in people through large clinical trials.

U.S. regulatory status

Current status: Not FDA-approved.

This means the FDA has not approved Pinealon as safe and effective for any medical use. No product containing it is an approved medicine in the United States.

Terms such as “bioregulator” are descriptive labels. They are not regulatory categories in the United States.

Why Peptide Labs does not sell Pinealon

Peptide Labs does not sell this compound. This page is general information, not medical advice. Our Peptide Guide exists to explain what these compounds are and how they are regulated, not to supply them.

Anyone with questions about Pinealon should speak with a licensed healthcare provider, who can explain the current evidence and the legal status in plain terms.

Related reading

See the full list of compound profiles in the Peptide Guide.